Net income · 2015–2025

AstraZeneca net income

$10.2B+45.3% · FY2025

AstraZeneca (AZN) reported $10.2B in net income for fiscal 2025, +45.3% year on year.

$2.8B2015$3.5B2016$3.0B2017$2.2B2018$1.3B2019$3.2B2020$112M2021$3.3B2022$6.0B2023$7.0B2024$10.2B2025
AstraZeneca — Net income, 2015–2025
Fiscal yearNet incomeChangeFiling
FY20252025-12-31$10.2B+45.3%Open →
FY20242024-12-31$7.0B+18.1%Open →
FY20232023-12-31$6.0B+81.1%Open →
FY20222022-12-31$3.3B+2,835.7%Open →
FY20212021-12-31$112M−96.5%Open →
FY20202020-12-31$3.2B+139.4%Open →
FY20192019-12-31$1.3B−38.1%Open →
FY20182018-12-31$2.2B−28.2%Open →
FY20172017-12-31$3.0B−14.2%Open →
FY20162016-12-31$3.5B+23.9%Open →
FY20152015-12-31$2.8B—Open →

Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +13.7%

Figures are reported under IFRS, in US dollars.

Net income at companies of similar size

Full ranking by net income →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=AstraZeneca net income |url=https://companiesranked.com/en/company/astrazeneca/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). AstraZeneca net income. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/net-income

BibTeX

@misc{companiesranked-en-company-astrazeneca-net-income-2026,
  author       = {{CompaniesRanked}},
  title        = {{AstraZeneca net income}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/net-income}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026

{{cite web |title=AstraZeneca net income — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← AstraZeneca overview